APA (7th ed.) Citation

Zhang, J., Wang, Z., Wei, X., Han, M., Yan, R., Ma, L., & Pan, Y. The suppression of the SPHK1/S1P/S1PR3 signaling pathway diminishes EGFR activation and increases the sensitivity of non-small cell lung cancer to gefitinib. Elsevier.

Chicago Style (17th ed.) Citation

Zhang, Jing, Zequn Wang, Xihua Wei, Mengyuan Han, Ribai Yan, Lijie Ma, and Yan Pan. The Suppression of the SPHK1/S1P/S1PR3 Signaling Pathway Diminishes EGFR Activation and Increases the Sensitivity of Non-small Cell Lung Cancer to Gefitinib. Elsevier.

MLA (9th ed.) Citation

Zhang, Jing, et al. The Suppression of the SPHK1/S1P/S1PR3 Signaling Pathway Diminishes EGFR Activation and Increases the Sensitivity of Non-small Cell Lung Cancer to Gefitinib. Elsevier.